The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient ...
Cancer vaccines have garnered attention as a potential treatment for cancer metastases. Nevertheless, the clinical response rate to vaccines remains < 30%. Nanoparticles stabilize vaccines and improve antigen recognition and presentation, resulting in high tumor penetration or accumulation, effective co...
544 A Study on Usefulness of rGCSF in Treating Bone Marrow Inhibition Arising from Chemotherapy in Ovarian Cancer Patients. HOSHINO T. , ADACHI T. , IWABUCHI H. , TANAKA T. , NAGATA J. , SAKAMOTO M. , MUTAI Y. , OKABE K. , NUTAHARA Y. , SATO H. , NEGISHI Y. Acta Obstetrica ...
Biomarkers that are redox-related or immune-related might help evaluate the status of patients with cancer and provide insight into how best to combine radiotherapy with biological treatments in each individual Abstract The past 20 years have seen dramatic changes in the delivery of radiation therapy...
Nanocarriers for cancer nano-immunotherapy Introduction Owing to the high risk of metastasis, cancer continues to be the most malignant illness globally, despite enormous advancements in therapy and diagnostics [1] Specifically, metastases are the leading causes of cancer and mortality in patients with ...
Plerixafor is a medication that stimulates the immune system to release more of a type of stem cell, hematopoietic progenitor cells (HPCs), from the bone marrow into the bloodstream. It is used to treat cancers originating in the blood cells. ...
The cancer stem cell hypothesis has become popular in the past few years, in part to provide an explanation of the recurrence of the disease following initial remission and apparent cure. Nevertheless, the concept that cancer is a developmental disease r
Thalidomide primarily treats multiple myeloma, but can haveserious side effects, so instead of pursuing large-scale research with thalidomide, Dr. McCrae used a drug with a similar chemical structure called pomalidomide, an FDA-approved drug for the treatment of bone marrow cancer. He performed api...
Biomarkers that are redox-related or immune-related might help evaluate the status of patients with cancer and provide insight into how best to combine radiotherapy with biological treatments in each individualAbstract The past 20 years have seen dramatic changes in the delivery of radiation therapy,...
Methods of treating, preventing and/or managing cancer as well as diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the admi